OCGN Stock Analysis: Buy, Sell, or Hold?
OCGN - Ocugen, Inc. Common Stock
$1.46
0.02 (1.04%)
▲
5d:
-19.17%
30d:
-22.19%
90d:
+9.4%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
OCGN is down 16.8% this week, but smart money is accumulating calls. Top strike: $2 2026-07-17 with 3,230 OI. Call ratio: 90% View Scanner →
Strength: 10.0/10
Get Alerted When OCGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
16 traders called OCGN this week
94% bullish • 1 bearish
94% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OCGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OCGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: OCGN is currently trading at $1.46, which is considered oversold relative to its 30-day fair value range of $1.62 to $1.88. From a valuation perspective, the stock is trading at a discount (Forward PE: 32.7) compared to its historical average (41.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OCGN is in a uptrend. Immediate support is located at $1.38, while resistance sits at $1.90.
Market Sentiment: OCGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.57 (+703.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OCGN is in a uptrend. Immediate support is located at $1.38, while resistance sits at $1.90.
Market Sentiment: OCGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.57 (+703.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.62 -
$1.88
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding OCGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 703.6% below Wall St target ($11.57)
- CAUTION: 5-day price weakness (-19.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.62 -
$1.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.38
Resistance Level
$1.90
Current Trend
Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.73
Wall Street Target
$11.57
(+703.6%)
Revenue Growth (YoY)
54.2%
Valuation Discount vs History
-7.8% cheaper
PE vs Historical
32.7 vs 41.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.8%
(market-implied from PE analysis)
1-Year Target
$1.33
(-8%)
2-Year Target
$1.22
(-15%)
3-Year Target
$1.13
(-22%)
3-Yr Target (if PE normalizes)
(PE: 33→42)
$1.44
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 32.7 to 41.7
Stabilization Target:
$1.83
(+27.4%)
PE Expansion Potential:
+27.4%
Share & Embed Analysis
Last updated: May 08, 2026 10:28 AM ET
Data refreshes hourly during market hours. Next update: 11:28 AM
Data refreshes hourly during market hours. Next update: 11:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 69 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 61 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 49 HOLD |
Advanced OCGN Option Strategies
Professional options setups generated by AI based on today's OCGN price and gamma walls.
